People who moved from weight loss shots to oral Wegovy lost an average of 4.1% more weight after three months, a finding shared on Facebook.
Recap by typeshit. Post by Facebook on Facebook.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
The News & Observer shares a look at how researchers are redesigning peptides so they can work as pills instead of injections.
The Telangana Drugs Control Administration issued a strict warning over unapproved weight-loss drugs and peptides being sold online in the Indian state.
Loading…